A grading system for the immunostaining of A, B and H blood group isoantigens in bladder carcinoma. 1988

C Busch, and P U Malmström, and B J Norlen, and J Sällström, and T Brodin, and A Lundblad
Department of Pathology, University Hospital, Uppsala, Sweden.

A test system for the evaluation of ABH blood group isoantigens in bladder carcinoma was developed. A highly standardized staining technique and a set of criteria for the judgement of staining extent and intensity was used. These variables are given numerical values which are multiplied to give a score (0-12) representing a semiquantitative estimate of the ABH-antigen expression. A consecutive series of 230 patients with bladder carcinoma was analyzed, using the test. The correlation between staining scores on the one hand and the tumor grade and stage on the other was assessed. Thirty-three percent of the tumors, irrespective of grade or stage, were completely negative, whereas 15% were positive to the same extent and intensity as normal mucosa. The remaining tumors showed intermediate patterns with respect to both extent and intensity of the expression with a progressive loss of detectable antigens with increasing grade and stage. The material was categorized with respect to the staining patterns for future analysis of the influence on prognostic parameters.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000017 ABO Blood-Group System The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane. ABH Blood Group,ABO Blood Group,ABO Factors,Blood Group H Type 1 Antigen,H Blood Group,H Blood Group System,ABO Blood Group System,Blood Group, ABH,Blood Group, ABO,Blood Group, H,Blood-Group System, ABO,Factors, ABO,System, ABO Blood-Group
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D001360 Avidin A specific protein in egg albumin that interacts with BIOTIN to render it unavailable to mammals, thereby producing biotin deficiency.

Related Publications

C Busch, and P U Malmström, and B J Norlen, and J Sällström, and T Brodin, and A Lundblad
February 1986, The Journal of urology,
C Busch, and P U Malmström, and B J Norlen, and J Sällström, and T Brodin, and A Lundblad
January 1999, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
C Busch, and P U Malmström, and B J Norlen, and J Sällström, and T Brodin, and A Lundblad
January 1983, Actas urologicas espanolas,
C Busch, and P U Malmström, and B J Norlen, and J Sällström, and T Brodin, and A Lundblad
January 1985, Urological research,
C Busch, and P U Malmström, and B J Norlen, and J Sällström, and T Brodin, and A Lundblad
January 1983, Cancer,
C Busch, and P U Malmström, and B J Norlen, and J Sällström, and T Brodin, and A Lundblad
April 1985, British journal of urology,
C Busch, and P U Malmström, and B J Norlen, and J Sällström, and T Brodin, and A Lundblad
January 1985, Pathologica,
C Busch, and P U Malmström, and B J Norlen, and J Sällström, and T Brodin, and A Lundblad
November 1973, Archives of pathology,
C Busch, and P U Malmström, and B J Norlen, and J Sällström, and T Brodin, and A Lundblad
September 1971, Cancer research,
C Busch, and P U Malmström, and B J Norlen, and J Sällström, and T Brodin, and A Lundblad
December 1971, Archives of pathology,
Copied contents to your clipboard!